High baseline or increasing anti-PLA2R1 antibody titers, on the other hand, are associated with persistent nephrotic syndrome and progressive loss of kidney function, which should lead to the prompt initiation of immunosuppressive therapy (6). Here, PLA2R1 is linked to nephrotic syndrome.